Physician profile
Stanley Mathew
NPI 1376644484
$36,532.80
in general payments reported to CMS, 2019-2025
40 companies · $622 in 2025
The $622 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $9,654 · 2021: $2,165 · 2022: $1,098 · 2023: $1,782 · 2024: $1,914 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,258 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,258.28 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $15,148.06 | 2019-2025 | Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $14,905.59 | 2019-2020 | |
| Lilly USA, LLC | $705.56 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $702.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $619.83 | 2019-2025 | Evenity, Prolia, Repatha |
| Sanofi-Aventis U.S. LLC | $497.32 | 2019-2025 | |
| Corcept Therapeutics | $480.43 | 2019-2025 | Korlym |
| Abbott Laboratories | $461.62 | 2021-2024 | Freestyle Libre 3 |
| Medtronic, INC. | $405.67 | 2021-2024 | Minimed 780g |
| Dexcom, INC. | $259.12 | 2019-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $206.63 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.75 | 2021-2024 | Jardiance |
| Insulet Corporation | $190.23 | 2019-2024 | Omnipod |
| Ibsa Pharma INC. | $176.31 | 2021-2025 | Tirosint, Licart, Tirosint |
| Mannkind Corporation | $158.04 | 2023-2025 | Afrezza |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequel Med Tech, LLC | $149.27 | 2025 | Twiist |
| Abbvie INC. | $121.10 | 2019-2025 | |
| Tandem Diabetes Care, INC. | $120.68 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Ascendis Pharma Endocrinology INC | $108.42 | 2023 | |
| Radius Health, INC. | $94.65 | 2021-2025 | Tymlos |
| Bayer Healthcare Pharmaceuticals INC. | $89.45 | 2022-2024 | |
| Amarin Pharma, INC. | $88.64 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $69.48 | 2021-2023 | Verquvo, Januvia, Belsomra |
| Alexion Pharmaceuticals, INC. | $67.88 | 2021-2025 | Strensiq |
| Xeris Pharmaceuticals, INC. | $56.60 | 2023-2024 | Recorlev, Gvoke Hypopen |
| Regeneron Healthcare Solutions, INC. | $54.63 | 2019-2020 | |
| Amphastar Pharmaceuticals, INC. | $54.05 | 2023-2024 | Baqsimi |
| Beta Bionics, INC. | $51.46 | 2024 | Ilet Bionic Pancreas |
| Recordati_rare_diseases_inc. | $46.08 | 2023 | Signifor Lar, Isturisa |
| Kyowa Kirin, INC. | $44.62 | 2023 | Crysvita |
| Medtronic Minimed, INC. | $39.85 | 2019 | |
| Intuity Medical INC | $37.14 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Ascensia Diabetes Care US INC. | $22.38 | 2022 | |
| Companion Medical, INC. | $18.29 | 2019 | |
| Exact Sciences Corporation | $15.58 | 2023 | Cologuard Collection Kit |
| Halozyme INC | $14.76 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.61 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.53 | 2024 | Unithroid |
| Pfizer INC. | $13.41 | 2023 | |
| Clarus Therapeutics INC. | $7.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.